Abstract:ObjectiveCaveolin-3 (CAV3) protein is known to be expressed specifically in various myocytes, but its physiological function remains unclear. CAV3, located at the cell membrane, may promote the sensitivity of the Akt signaling pathway, which is closely related to glucose metabolism and to cell growth and proliferation.MethodsThe CAV3 gene was stably transfected into C2C12 muscle cells, and the effects were evaluated by biochemical assays, WB and confocal microscopy for the observation of cellular glucose metab… Show more
“…The Caveolin-3 also interacts with phosphofructokinase-M (PFK-M), a key enzyme in the control of glycolysis in a glucose dependent manner, and may play a role in the regulation of energy metabolism in skeletal muscle fibers [ 90 ]. Shang et al [ 91 ] have shown that in skeletal muscle cell line C2C12, Cav3 protein can activate Akt signaling and increase glucose transporter type 4 (GLUT4) localization at the cell surface, leading to increased glucose uptake. This in turn promotes myocytes’ growth and proliferation.…”
Section: Role Of Caveolin-3 In Energy Metabolismmentioning
Caveolae are the cholesterol-rich small invaginations of the plasma membrane present in many cell types including adipocytes, endothelial cells, epithelial cells, fibroblasts, smooth muscles, skeletal muscles and cardiac muscles. They serve as specialized platforms for many signaling molecules and regulate important cellular processes like energy metabolism, lipid metabolism, mitochondria homeostasis, and mechano-transduction. Caveolae can be internalized together with associated cargo. The caveolae-dependent endocytic pathway plays a role in the withdrawal of many plasma membrane components that can be sent for degradation or recycled back to the cell surface. Caveolae are formed by oligomerization of caveolin proteins. Caveolin-3 is a muscle-specific isoform, whose malfunction is associated with several diseases including diabetes, cancer, atherosclerosis, and cardiovascular diseases. Mutations in Caveolin-3 are known to cause muscular dystrophies that are collectively called caveolinopathies. Altered expression of Caveolin-3 is also observed in Duchenne’s muscular dystrophy, which is likely a part of the pathological process leading to muscle weakness. This review summarizes the major functions of Caveolin-3 in skeletal muscles and discusses its involvement in the pathology of muscular dystrophies.
“…The Caveolin-3 also interacts with phosphofructokinase-M (PFK-M), a key enzyme in the control of glycolysis in a glucose dependent manner, and may play a role in the regulation of energy metabolism in skeletal muscle fibers [ 90 ]. Shang et al [ 91 ] have shown that in skeletal muscle cell line C2C12, Cav3 protein can activate Akt signaling and increase glucose transporter type 4 (GLUT4) localization at the cell surface, leading to increased glucose uptake. This in turn promotes myocytes’ growth and proliferation.…”
Section: Role Of Caveolin-3 In Energy Metabolismmentioning
Caveolae are the cholesterol-rich small invaginations of the plasma membrane present in many cell types including adipocytes, endothelial cells, epithelial cells, fibroblasts, smooth muscles, skeletal muscles and cardiac muscles. They serve as specialized platforms for many signaling molecules and regulate important cellular processes like energy metabolism, lipid metabolism, mitochondria homeostasis, and mechano-transduction. Caveolae can be internalized together with associated cargo. The caveolae-dependent endocytic pathway plays a role in the withdrawal of many plasma membrane components that can be sent for degradation or recycled back to the cell surface. Caveolae are formed by oligomerization of caveolin proteins. Caveolin-3 is a muscle-specific isoform, whose malfunction is associated with several diseases including diabetes, cancer, atherosclerosis, and cardiovascular diseases. Mutations in Caveolin-3 are known to cause muscular dystrophies that are collectively called caveolinopathies. Altered expression of Caveolin-3 is also observed in Duchenne’s muscular dystrophy, which is likely a part of the pathological process leading to muscle weakness. This review summarizes the major functions of Caveolin-3 in skeletal muscles and discusses its involvement in the pathology of muscular dystrophies.
“…The K15N mutation reduces the CAV3 protein on the muscle cell membranes by ~95% (32). This reduction causes the abnormal localization of proto-oncogene tyrosine-protein kinase Src on the Golgi (33) and leads to CAV3 protein retention (15). Consistent with these data, western blot analysis performed in the current study indicated that the CAV3 K15N mutation led to decreased recombinant CAV3 protein expression in muscle cells.…”
Section: Discussionmentioning
confidence: 99%
“…However, IR and GLUT-4 are associated with glucose metabolism and are localized to membrane caveolae, with their expression being regulated by CAV3 on the cell membrane. CAV3 can enhance the expression of IR (38–40) by stimulating IR kinase activity, increasing the stability of IR at the sarcolemmal membrane and reducing its degradation (12), stimulating the phosphorylation of IRS-1 and activating the PI3K/AKT signaling pathway (15,18). Activated AKT not only promoted the translocation of GLUT-4 to the plasma membrane and enhanced glucose uptake, but also induced the phosphorylation of GSK3β, which leads to glycogen synthesis via the activation of glycogen synthase (41,42).…”
Section: Discussionmentioning
confidence: 99%
“…The results of full-gene scans indicated that the total number of gene variations in the CAV3 gene in patients with T2DM was 48%, compared with 7% in healthy patients (14). A previous study also assessed the transfection of wild-type CAV3 (WT) in muscle cells and found that the PI3K/AKT signaling pathway were activated, increasing the plasma membrane localization of glucose transporter type 4 (GLUT-4) and increasing glucose uptake, cell growth and proliferation (15). One mutation of the CAV3 gene (P104L) in patients with myasthenia has been revealed to be associated with the inhibition of insulin-stimulated glucose uptake and glycogen synthesis in myocytes (16).…”
Caveolin-3 (CAV3) is a muscle-specific protein present within the muscle cell membrane that affects signaling pathways, including the insulin signaling pathway. A previous assessment of patients with newly developed type 2 diabetes (T2DM) demonstrated that CAV3 gene mutations may lead to changes in protein secondary structure. A severe CAV3 P104L mutation has previously been indicated to influence the phosphorylation of skeletal muscle cells and result in impaired glucose metabolism. In the present study, the effect of CAV3 K15N gene transfection in C2C12 cells was assessed. Transfection with K15N reduced the expression of total CAV3 and AKT2 proteins in the cells, and the translocation of glucose transporter type 4 to the muscle cell membrane, which resulted in decreased glucose uptake and glycogen synthesis in myocytes. In conclusion, these results indicate that the CAV3 K15N mutation may cause insulin-stimulated impaired glucose metabolism in myocytes, which may contribute to the development of T2DM.
“…Overexpression of dominant-negative cav3 leads to decreased glucose uptake and glycogen synthesis in C2C12 cells, which is attributed to decreased Akt phosphorylation (43–45). Conversely, an increase in wildtype cav3 expression is sufficient to enhance Akt phosphorylation and glucose uptake (46). Indeed, LPCAT3 knockdown substantially increased cav3 content in C2C12 myotubes (Figure 5A).…”
39 Aberrant lipid metabolism promotes the development of skeletal muscle insulin resistance, but 40 the exact identity of lipid-mediated mechanisms relevant to human obesity remains unclear. A 41 comprehensive lipidomic analyses of primary myocytes from lean insulin-sensitive (LN) and 42 obese insulin-resistant (OB) individuals revealed several species of lysophospholipids (lyso-PL) 43 that were differentially-abundant. These changes coincided with greater expression of 44 lysophosphatidylcholine acyltransferase 3 (LPCAT3), an enzyme involved in phospholipid 45 transacylation (Lands cycle). Strikingly, mice with skeletal muscle-specific knockout of LPCAT3 46 (LPCAT3-MKO) exhibited greater muscle lyso-PC/PC, concomitant with greater insulin 47 sensitivity in vivo and insulin-stimulated skeletal muscle glucose uptake ex vivo. Absence of 48 LPCAT3 reduced phospholipid packing of the cellular membranes and increased plasma 49membrane lipid clustering, suggesting that LPCAT3 affects insulin receptor phosphorylation by 50 modulating plasma membrane lipid organization. In conclusion, obesity accelerates the skeletal 51 muscle Lands cycle, whose consequence might induce the disruption of plasma membrane 52 organization that suppresses muscle insulin action. 53Notably, the increase occurred at the level of the insulin receptor (IR), a node that is localized in 131 the phospholipid-rich plasma membrane. Consequently, LPCAT3 deletion enhanced insulin-132 stimulated glycogen synthesis ( Figure 2H), suggesting that this intervention increases skeletal 133 muscle insulin sensitivity in vitro (due to low GLUT4:GLUT1 stoichiometry, insulin-stimulated 134 glucose uptake is not an ideal surrogate for insulin sensitivity in C2C12 myotubes). LPCAT3 135 knockdown also enhanced insulin signaling in HSkMC from obese subjects ( Figure 2G). 136
137The organization and clustering of plasma membrane microdomains is linked to the induction of 138 tyrosine-kinase signaling events, such as IR signaling (29-31). Because LPCAT3 deletion 139
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.